8
total announcements
LASA.NS · 15 min delayed
Lasa Supergenerics Limited
Lasa Supergenerics Limited has been asked by the NSE to clarify its financial results for the quarter ended 30-Jun-2026 due to non-compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has appointed Mr. Janardan Savala as an Additional Director in the capacity of Executive Director, subject to approval from members at the ensuing General Meeting/Postal Ballot.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange regarding the cessation of Mr. Ganesh as Executive Director of the company with effect from August 25, 2026.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has submitted its integrated filing for the quarter ended June 30, 2026, including unaudited financial results and a limited review report from its statutory auditor. The company's factory in Ratnagiri suffered a fire incident in May 2025, resulting in significant damage and disruption to operations. The auditor's report highlights the exceptional item of uninsured loss due to the fire incident.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has submitted its financial results for the period ended June 30, 2026.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has submitted its Structured Digital Database (SDD) compliance certificate for the quarter ended June 30, 2026, confirming the company's SDD is in place and meets all requirements.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.